![Simon Pimstone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Pimstone
Président chez
EUPRAXIA PHARMACEUTICALS INC.
Fortune : 345 127 $ au 31/05/2026
Profil
Simon Neil Pimstone is the founder of XYON Health, Inc., founded in 2019, serving as Chief Executive Officer & Director.
Dr. Pimstone was the founder of Xenon Pharmaceuticals, Inc., founded in 1996, serving as Non-Executive Chairman from 2022 to 2024.
Current jobs include Chairman at Topirx Pharmaceuticals, Inc. since 2019, Independent Chairman at Eupraxia Pharmaceuticals, Inc. since 2013, and Member of Young Presidents' Organization (Canada).
Former jobs include Chairman at LifeSciences British Columbia, Providence Health Care Research Institute, Accuro Technologies, Inc., and Alpha-9 Oncology, Inc. from 2020 to 2024; Vice Chairman at BIOTECanada and British Columbia Clinical Research Infrastructure Network; Director at Enject, Inc., Michael Smith Foundation for Health Research, Allergen NCE, Inc., Indel Therapeutics, Inc., Centre for Molecular Medicine & Therapeutic, Cyon Therapeutics, Inc., and Providence Health Care (Vancouver); Clinical Associate Professor at the University of British Columbia; and Member of the Science, Technology & Innovation Council.
Education includes an undergraduate degree from the University of Cape Town in 1991 and a doctorate from the University of Amsterdam in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2026 | 48 678 ( 0,08 % ) | 345 127 $ | 31/05/2026 |
Postes actifs de Simon Pimstone
| Sociétés | Poste | Début |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Président | 14/01/2013 |
Young Presidents' Organization (Canada)
 Young Presidents' Organization (Canada) Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which helps young chief executives to engage, learn, and grow | Corporate Officer/Principal | - |
Topirx Pharmaceuticals, Inc.
 Topirx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Président | 01/01/2019 |
XYON Health, Inc.
 XYON Health, Inc. Medical/Nursing ServicesHealth Services Provides online hair loss treatment services and sells related products | Fondateur | 01/01/2019 |
Anciens postes connus de Simon Pimstone
| Sociétés | Poste | Fin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Directeur Général | 03/06/2021 |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Président | 01/01/2024 |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Président | - |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
Allergen NCE, Inc.
 Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research to prevent, treat and manage allergic diseases and asthma | Directeur/Membre du Conseil | - |
Formation de Simon Pimstone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Enject, Inc.
 Enject, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development | Health Technology |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Young Presidents' Organization (Canada)
Young Presidents' Organization (Canada) Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which helps young chief executives to engage, learn, and grow | Commercial Services |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous Operates as health research funding agency | Miscellaneous |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Science, Technology & Innovation Council
 Science, Technology & Innovation Council Miscellaneous Commercial ServicesCommercial Services Offers science, technology and innovation services to government | Commercial Services |
Allergen NCE, Inc.
Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research to prevent, treat and manage allergic diseases and asthma | Commercial Services |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Centre for Molecular Medicine & Therapeutic
 Centre for Molecular Medicine & Therapeutic The Centre for Molecular Medicine & Therapeutics operates within the University of British Columbia and is part of the university’s broader efforts in medical research and education, including advancing medical treatments through AI development and fostering academic collaborations. The private company is based in Vancouver, Canada. The Canadian company was founded by Michael R. Hayden. | |
British Columbia Clinical Research Infrastructure Network
 British Columbia Clinical Research Infrastructure Network Miscellaneous Commercial ServicesCommercial Services Provide clinical research services | Commercial Services |
Providence Health Care Research Institute
 Providence Health Care Research Institute Miscellaneous Commercial ServicesCommercial Services Provides healthcare research services | Commercial Services |
Cyon Therapeutics, Inc.
 Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel treatment platforms and technologies | Commercial Services |
Providence Health Care (Vancouver)
 Providence Health Care (Vancouver) Hospital/Nursing ManagementHealth Services Functions as non profit healthcare organization that operates hospital | Health Services |
Accuro Technologies, Inc. | |
Topirx Pharmaceuticals, Inc.
Topirx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
XYON Health, Inc.
XYON Health, Inc. Medical/Nursing ServicesHealth Services Provides online hair loss treatment services and sells related products | Health Services |
